79 results
management treatment pharmacology diagnosis hivaids infections opportunistic prevention checklist algorithm differential nephrology glomerulonephritis covid19 pathology table clinical coronavirus epinephrine hematology
Membranoproliferative Glomerulonephritis (MPGN) AKA: Mesangiocapillary GN • Active Urine Sediment (dysmorphic RBC, RBC casts, +/- proteinuria)
Glomerulonephritis (MPGN ... Mesangiocapillary GN ... Complement-Mediated MGPN ... , CFHR5 neph) MPGN ... Glomerulonephritis #MPGN
Intrinsic Renal Disease - Differential Diagnosis Vascular: • Macrovascular: Renal artery occlusion, Fibromuscular disease • Microvascular: TTP/HUS,
, Amyloidosis, MPGN ... • Nephritic: RPGN ... , IgA, Alport, MPGN
Rapidly Progressive Glomerulonephritis (RPGN) RPGN has three primary pathophysiologic causes differentiated by immunofluorescence Immune Complex Mediated (granular staining):
Glomerulonephritis (RPGN ... ) RPGN has three ... Complement: Post-strep GN ... StanfordChiefs #RPGN
MGH Sedation protocol for mechanically ventilated COVID-19 patients #Sedation #Analgesia #Protocol #COVID19 #CriticalCare #Treatment #MGH #Management #Coronavirus
MGH Sedation protocol ... Protocol #COVID19 #CriticalCare ... #Treatment #MGH
Mass General Hospital COVID19 Critical Care Treatment Guide #COVID19 #CriticalCare #Treatment #MGH #Management #Coronavirus #SARSCOV2
Guide #COVID19 #CriticalCare ... #Treatment #MGH
Cryoglobulinemia Classification Types Type 1: Monoclonal IgM (rarely IgG/lgA) • Raynaud phenomenon, Digital ulcers/gangrene, Livedo reticularis, Hyperviscosity
Liver, kidney (MPGN
Recurrent / Breakthrough DVT During Anticoagulation Subtherapeutic Anticoagulation Hypercoagulable State - Antithrombin deficiency - Hypercoagulability ot
- APLS - MPN
Rapidly Progressive Glomerulonephritis (RPGN) - Loss of kidney function over a short period of tirne
Glomerulonephritis (RPGN ... post-infectious GN ... Glomerulonephritis #RPGN
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals Induction therapy: • AmBd (0.7–1.0
IDSA Treatment Recommendations ... AmBd (0.7–1.0 mg ... day) or ABLC (5 mg ... AmBd (0.7–1.0 mg ... Meningoencephalitis #IDSA
Effect of Selected Diseases on Complement Levels - C3, C4 • SLE C3 ↓ C4 ↓↓
C3 ↓ C4 ↓↓ • MCGN
No results found for "MPGN mgn idsa criticalcare"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #MPGN #mgn #idsa #criticalcare